Article
Calyx announced it has entered into a partnership with Qynapse. The partnership enables Calyx to adopt and deliver Qynapse's AI-powered neuroimaging analysis solutions, QyScore® and QyPredict® to its global pharmaceutical and biotech customers as they develop new medical treatments for central nervous system (CNS) disorders.
Read more about the partnership here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.